CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors. // Neural Networks. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626009408?dgcid=rss_sd_all
CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors. Neural Networks. https://www.sciencedirect.com/science/article/pii/S1525001626009408?dgcid=rss_sd_all
“CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors.” Neural Networks.
@article{article6264,
title = {CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors},
journal = {Neural Networks},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626009408?dgcid=rss_sd_all}
}
Publication date: Available online 17 November 2026 Source: Asian Journal of Sport and Exercise Psychology Author(s): Triana Kesuma Dewi, Muchlisah Audina Sudirman, Cheng-Ta Yang
Publication date: Available online 29 October 2026 Source: Asian Journal of Sport and Exercise Psychology Author(s): Sahen Gupta, Nandini Choudhary, Rachna Aravind
Publication date: Available online 13 October 2026 Source: Asian Journal of Sport and Exercise Psychology Author(s): Jeswenny Fresshila John, Ngien Siong Chin, Yee Cheng Kueh, Garry Kuan